Filing Details

Accession Number:
0001104659-23-049097
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-24 17:25:03
Reporting Period:
2023-04-20
Accepted Time:
2023-04-24 17:25:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1856725 Rani Therapeutics Holdings Inc. RANI () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1794292 South Lake One Llc Avenida Presidente Riesco 5711,
Oficina 1603, Las Condes
Santiago F3 7550000
No No Yes No
1876412 Partnership Limited Investments Cone South Avenida Presidente Riesco 5711,
Oficina 1603, Las Condes
Santiago F3 7550000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-04-20 1,850 $5.32 6,839,698 No 4 P Indirect Shares indirectly held through South Lake One LLC
Class A Common Stock Acquisiton 2023-04-21 4,100 $4.93 6,843,798 No 4 P Indirect Shares indirectly held through South Lake One LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Shares indirectly held through South Lake One LLC
No 4 P Indirect Shares indirectly held through South Lake One LLC
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.32 to $5.38 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.